RSS   Newsletter   Contact   Advertise with us
Post Online Media

Gyros appoints Frank Witney as chairman

Frank WitneyGyros Protein Technologies AB, a biotechnology company, announced the appointment of Frank Witney as chairman of the board.

Dr. Witney has over 30 years of experience in leadership and innovation in the life science industry. Most recently he was President and CEO of Affymetrix, which was acquired by Thermo Fisher Scientific in March 2016.

Prior to this, Dr. Witney was President and Chief Executive Officer of Dionex, leading to the company’s successful acquisition by Thermo Fisher Scientific in 2011.

Earlier executive roles include President and CEO of Panomics, acquired by Affymetrix, and COO at Packard Biosciences, acquired by PerkinElmer, after which he served as President of their Life Sciences Group.

Earlier in his career Dr. Witney held a series of positions at Bio-Rad Laboratories, including Group Operations Manager of the Life Science Group, leading efforts to enter rapidly growing markets for proteomic and bioassay technologies.

Dr. Witney holds a doctorate in molecular and cell biology from Indiana University, and was a post-doctoral fellow at the National Institutes of Health. He is also a member of the Board of Directors of Cerus Corporation and Exagen Diagnostics, Inc.

David Patteson, prior chairman of Protein Technologies, Inc. remains as a Director.


 LATEST MOVES FROM Sweden 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy